Before & After
- +357 22818250
- info@healthpharma.eu
- 2 Sofouli Street, Chanteclair Building, Offices 503-505, 5th Floor, 1096 Nicosia, Cyprus
- Mon-Fri: 8:00 to 17:30
For a youthful, firmer you, ask for
Sculptra®
Sculptra® activates the power of your skin by revitalizing collagen production.¹ With Sculptra®, you will renew skin thickness and firmness and correct shallow to deep wrinkles and folds.²
Sculptra® gradually builds the foundations of the youthful, firmer you, day after day.³
Why Sculptra®?
Sculptra® activates the skin’s ability to produce collagen, restoring the skin’s structure and renewing its natural firmness.4 Collagen is a fibrous protein in the deeper layers of your skin and is key in making your skin look young and healthy. As you age, your body’s collagen production decreases. The loss of collagen will in time lead to loose and saggy skin and the formation of facial wrinkles and folds.5
Sculptra® is the original collagen stimulator that will renew your skin in a gradual and long-lasting way by stimulating collagen production.6 Sculptra® gives you control of your skin and the power to look as great as you feel.
TREATMENT AREAS
Sculptra® volume and firmness to areas of your face that have become loose and saggy.7 Examples include smile lines (also called nasolabial folds), laugh lines (or marionette lines) and chin wrinkles. The treatment helps gradually replace lost collagen and results may last for more than two years.8 Sculptra®will reinvigorate your skin and bring back your youthful appearance.
80% of users were still satisfied with their Sculptra® treatment 25 months after their last injection, according to a clinical study.9
Your Sculptra® treatment
Sculptra® is injected in the deep layers of your skin to stimulate its own collagen production.10 You will gradually notice visible improvements of skin firmness and fullness, and results can last for more than two years.11 On average, three treatment sessions are needed over a few months.
Immediately after each treatment session, you may experience some swelling that will temporarily reduce wrinkles and folds. Thereafter, the gradual process of collagen replacement starts. Sculptra® works subtly, improving facial areas gradually to give you a youthful and natural-looking result that lasts.
How it works
The active ingredient in Sculptra® is poly-L-Lactic acid, PLLA. PLLA is a biodegradable substance that has been used for decades in dissolvable stitches for wound management. When PLLA is injected in the deeper layers of your skin, it helps stimulate your skin’s own natural collagen production.12 Thereby, your skin’s inner structure is improved and you will regain skin volume that has been lost to aging.13
80% rated Sculptra® as good to excellent after 25 months
100% of patients would recommend Sculptra® to a friend15
Proven aesthetic results since 199916
FREQUENTLY ASKED QUESTIONS
Before your first treatment you will always have a consultation. Think through what you want to achieve and any questions that you want to ask your healthcare practitioner. You will be informed about how Sculptra works and how it can be used in a safe way to improve your skin’s firmness by stimulating your body’s own collagen production.
Your healthcare practitioner will also ask you about your medical history. After the consultation you should feel well informed about Sculptra and know what results to expect.
Make sure that the clinic has a qualified practitioner(s) so that your treatment will be performed correctly. You could always search in national registers of licensed aesthetic treatment specialists. Your treatment should be performed in a medical environment that provides privacy and is spotlessly clean. You can always request to see training certificates and insurance certificates to ensure that your healthcare practitioner has received the appropriate training and is insured for the treatment.
Specialists who have been trained to inject Sculptra for natural collagen stimulation, and are licensed to practice within your country or state, may administer the treatment. This can include physician assistants, nurse practitioners, registered nurses and other trained personnel.
Your healthcare practitioner should provide you with comprehensive information about how Sculptra can stimulate the formation of collagen in a natural way and give you a detailed explanation regarding your treatment.
This is what you should expect:
• Information about the possibilities and limitations of the treatment
• Information about possible side effects and precautions for treatment
• Information about the cost of the treatment and follow-up treatments
• That your questions are answered to your full satisfaction
Sculptra is injected to correct shallow to deep wrinkles and folds, by stimulating the skin’s own collagen production. Administered with the appropriate injection technique from a trained specialist, Sculptra is clinically approved for:
• Deep folds between the nose and mouth (nasolabial folds), also called “smile lines”
• Lines framing the mouth (marionette lines)
• Chin wrinkles
Please note that indications vary between countries. Please consult your healthcare practitioner for more information.
Sculptra is injected to correct shallow to deep wrinkles and folds, by stimulating the skin’s own collagen production. Administered with the appropriate injection technique from a trained specialist, Sculptra is clinically approved for:
• Deep folds between the nose and mouth (nasolabial folds), also called “smile lines”
• Lines framing the mouth (marionette lines)
• Chin wrinkles
Please note that indications vary between countries. Please consult your healthcare practitioner for more information.
On average, a series of three treatment sessions over the course of a few months may be needed. The number of injections at each session will vary, depending on the degree of correction needed and the treatment plan determined by you and your healthcare practitioner.
As with any injection, some pain at the treatment site is possible, but your healthcare practitioner may use a topical anesthetic to ease any discomfort.
Sculptra is designed to give you noticeable results that emerge gradually with increased collagen production. Don’t be disappointed if you don’t see immediate results. A few days after treatment, you may look as you did before treatment. This is normal and temporary. The Sculptra regimen delivers its full effects with an average of three treatment sessions over the course of a few months. Because results happen gradually, you will see subtle, yet noticeable, results in the reduction of facial wrinkles and folds by comparing images before treatment and a couple months following treatment.*
*Safety and effectiveness of Sculptra have not been evaluated in areas other than nasolabial wrinkles and folds.
In the days following your treatment, keep a few things in mind for swift healing and optimum results:
Cold pack: A cold pack or ice pack will help reduce any common swelling. Within the first 24 hours of treatment, apply a cloth-wrapped cold pack to the treated area for a few minutes at a time. Never apply ice directly to the skin.
Facial massage: Massage the treated area for five minutes five times a day for five days after treatment, as recommended by your healthcare practitioner.
Avoid sunlight: After treatment, excessive sunlight and UV lamp exposure should be avoided until any initial swelling and redness go away. Your healthcare practitioner will provide guidelines on sunscreen protection and how to avoid excessive sunlight.
If there are no complications, you may apply makeup several hours after treatment. Be sure to consult your healthcare practitioner after treatment.
Sculptra was CE approved for aesthetic use in the European market in 1999 and is FDA approved in the United States. Sculptra is made of a synthetic material called poly-L-lactic acid that is absorbed naturally by the body and has been used for years in dissolvable stitches. Since Sculptra does not contain any human or animal components, no allergy testing is needed prior to treatments.
Common side effects reported include pain at the treatment area, redness, bruising, tenderness, itching and lumps, bleeding or swelling. Small bumps under the skin can sometimes be noticeable when pressing on the treated area. Larger lumps, with or without inflammation, have also been reported. Common side effects usually resolve spontaneously within 2 to 7 days. If you are experiencing side effects, talk to your healthcare practitioner.
Sculptra is indicated for use in people with healthy immune systems as a single regimen for the correction of shallow to deep nasolabial folds and other facial wrinkles by stimulating collagen production. You should not receive treatment if you have an active skin infection or skin inflammation near the planned injection site.
Sculptra should not be used by people that are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding or under 18 years of age.
Sculptra is distributed by Galderma. Galderma is a pharmaceutical company with over 6,000 employees worldwide. The company specializes in dermatology and is present in more than 100 countries.
Skin insights
Renew skin structure and reduce saggy skin with a Sculptra® collagen treatment
Aging affects people differently, some are affected by facial volume loss, whereas others are more troubled by sagging skin or skin laxit
A collagen treatment can improve skin laxity as well as improve overall volume.
OUR PORTFOLIO OF PRODUCTS
Galderma has developed a diverse portfolio of products that work holistically together.
Refine your facial features by lifting and shaping contours, filling lines and wrinkles or creating natural volume.
Restore the tension of facial muscles associated with crow´s feet and frown lines to show how you truly feel inside.
Refresh your skin from within with a boost of deep hydration, for a refreshed and vibrant look that lasts.
REFERENCES
1 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
2 Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.
3 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg
2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.;
Moyle GJ et al. HIV Med 2004;5(2):82–7.; Bohnert K et al. Plast Reconstr Surg
2019;127(4):1684–92
4 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
5 Fisher GJ et al. Arch Dermatol 2008;144(5):666–72.; Werschler WP et al. J Clin Aesthet Dermatol 2015;8(10 Suppl):S2–S7.
6 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
7 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
8 Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.
9 Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
10 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
11 Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
12 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
13 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.; Chen HH et al. JAMA Facial Plast Surg 2015;17(1):39–43.
14 Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
15 Mest DR and Humble G. Dermatol Surg 2006;32(11):1336–45.
16 Sculptra was developed and CE approved for aesthetic use in the European market in 1999.